Jonathan E. Freeman - 11 Sep 2024 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
/s/ Robert M. Infarinato, Attorney-in-Fact
Issuer symbol
PHIO
Transactions as of
11 Sep 2024
Net transactions value
$0
Form type
4
Filing time
13 Sep 2024, 14:59:52 UTC
Previous filing
22 Feb 2023
Next filing
15 Sep 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common Stock, $0.0001 par value Award $0 +1,000 $0.000000 1,000 11 Sep 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest on the first anniversary of the grant.
F2 Includes shares of common stock underlying unvested restricted stock units.